 HANOVER, MD, Aug. 23, 2021 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. Nasdaq: PCSA, a clinical stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have an unmet medical need condition today announced it will present at the World Orphan Drug Congress USA 2022 Conference, to be held from August 25-27, 2022. 